Correlation Between Gensight Biologics and Aelis Farma

Can any of the company-specific risk be diversified away by investing in both Gensight Biologics and Aelis Farma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gensight Biologics and Aelis Farma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gensight Biologics SA and Aelis Farma SA, you can compare the effects of market volatilities on Gensight Biologics and Aelis Farma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gensight Biologics with a short position of Aelis Farma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gensight Biologics and Aelis Farma.

Diversification Opportunities for Gensight Biologics and Aelis Farma

0.71

Correlation Coefficient

Gensight Biologics  Aelis Farma

Poor diversification

The 3 months correlation between Gensight and Aelis is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Gensight Biologics SA and Aelis Farma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aelis Farma SA and Gensight Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gensight Biologics SA are associated (or correlated) with Aelis Farma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aelis Farma SA has no effect on the direction of Gensight Biologics i.e., Gensight Biologics and Aelis Farma go up and down completely randomly.

Pair Corralation between Gensight Biologics and Aelis Farma

Assuming the 90 days trading horizon Gensight Biologics SA is expected to generate 1.47 times more return on investment than Aelis Farma. However, Gensight Biologics is 1.47 times more volatile than Aelis Farma SA. It trades about -0.04 of its potential returns per unit of risk. Aelis Farma SA is currently generating about -0.38 per unit of risk. If you would invest  39.00  in Gensight Biologics SA on September 16, 2024 and sell it today you would lose (7.00) from holding Gensight Biologics SA or give up 17.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Gensight Biologics SA  vs.  Aelis Farma SA

Gensight Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gensight Biologics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Aelis Farma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aelis Farma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Gensight Biologics and Aelis Farma

The main advantage of trading using opposite Gensight Biologics and Aelis Farma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gensight Biologics position performs unexpectedly, Aelis Farma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aelis Farma will offset losses from the drop in Aelis Farma's long position.

The idea behind Gensight Biologics SA and Aelis Farma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.